Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal
A new network meta-analysis reveals that high-dose psilocybin may be as effective as escitalopram for treating depressive symptoms, with a standardized mean difference of 0.31 compared to placebo in antidepressant trials.
Psychiatry September 10th 2024
The New England Journal of Medicine
Sexual dysfunction negatively affects mental health, vitality, and social functioning, with an impact on quality of life comparable to chronic back pain or diabetes.
Endocrinology, Diabetes, Metabolism September 4th 2024
Psychiatrist.com
A 24-year prospective study involving 362 inpatients with borderline personality disorder (BPD) has found that while the prevalence of symptomatic disorders declines over time, the absence of substance use disorders is the strongest predictor of BPD recovery.
Psychiatry August 27th 2024
Postpartum OCD affects 2-24% of new mothers, often manifesting as intrusive thoughts of infant harm accompanied by compulsive checking behaviors.
Obstetrics & Gynecology August 20th 2024
Neurology Learning Network
CBTI offers a non-pharmacological approach to treating insomnia, focusing on behavioral changes that can lead to long-term improvements in sleep quality.
Neurology August 14th 2024
MDLinx
Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.
Endocrinology, Diabetes, Metabolism August 13th 2024